Vitamin D: Current guidelines and future outlook

Anticancer Research

Volumn 38, Issue 2, 2018, Pages 1145-1151

  Pilz, Stefan ^a   Trummer, Christian ^a   Pandis, Marlene ^a   Schwetz, Verena ^a   Aberer, Felix ^a   Grübler, Martin ^a   Verheyen, Nicolas ^b   Tomaschitz, Andreas ^c,d   März, Winfried ^a,d,e  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c Specialist Clinic of Rehabilitation Bad Gleichenberg   (Austria)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e SYNLAB ACADEMY   (Germany)

Author keywords

25(OH)D; Epidemiology; Guidelines; Review; Supplementation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; VITAMIN;

DIETARY REFERENCE INTAKE; HUMAN; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; VITAMIN INTAKE; BLOOD; DIETARY SUPPLEMENT; STANDARDS; VITAMIN D DEFICIENCY;

DIETARY SUPPLEMENTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 85041668272     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: 10.21873/anticanres.12333     Document Type: Review

References (58)

1. Uday S and Högler W: Nutritional rickets and osteomalacia in the twenty-first century: Revised concepts, public health, and prevention strategies. Curr Osteoporos Rep 6: 667-675, 2017.
2. Pilz S, Gaksch M, Hartaigh BÓ, Tomaschitz A and März W: Vitamin D in preventive medicine. Anticancer Res 35: 1161- 1170, 2015.
3. Theodoratou E, Tzoulaki I, Zgaga L and Ioannidis JP: Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348: g2035, 2014.
4. Feldman D, Krishnan AV, Swami S, Giovannucci E and Feldman BJ:The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 14: 342-357, 2014.
5. Pilz S, Verheyen N, Grübler MR, Tomaschitz A and März W: Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol 13: 404-417, 2016.
6. Autier P, Boniol M, Pizot C and Mullie P: Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2: 76-89, 2014.
7. Rejnmark L, Bislev LS, Cashman KD, Eiríksdottir G, Gaksch M, Grübler M, Grimnes G, Gudnason V, Lips P, Pilz S, van Schoor NM, Kiely M and Jorde R: Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data. PLoS One 12: e0180512, 2017.
8. Holick MF: The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18: 153-165, 2017.
9. Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, Moreno L, Damsgaard CT, Michaelsen KF, Mølgaard C, Jorde R, Grimnes G, Moschonis G, Mavrogianni C, Manios Y, Thamm M, Mensink GB, Rabenberg M, Busch MA, Cox L, Meadows S, Goldberg G, Prentice A, Dekker JM, Nijpels G, Pilz S, Swart KM, van Schoor NM, Lips P, Eiriksdottir G, Gudnason V, Cotch MF, Koskinen S, Lamberg-Allardt C, Durazo-Arvizu RA and Sempos CT, Kiely M: Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr 103: 1033-1044, 2016.
10. Bouillon R: Comparative analysis of nutritional guidelines for vitamin D: Nat Rev Endocrinol 13: 466-479, 2017.
11. Christakos S, Dhawan P, Verstuyf A, Verlinden L and Carmeliet G: Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 96: 365-408, 2016.
12. Cashman KD and Kiely M: EURRECA-Estimating vitamin D requirements for deriving dietary reference values. Crit Rev Food Sci Nutr 53: 1097-1109, 2013.
13. Cashman KD and Kiely M: Recommended dietary intakes for vitamin D: Where do they come from, what do they achieve and how can we meet them? J Hum Nutr Diet 27: 434-442, 2014.
14. Cashman KD: Vitamin D: dietary requirements and food fortification as a means of helping achieve adequate vitamin D status. J Steroid Biochem Mol Biol 148: 19-26, 2015.
15. Institute of Medicine. Dietary Reference Intakes: the essential guide to nutrient requirements. Washington, DC: National Academies Press, 2006.
16. Atkinson SA: Defining the process of Dietary Reference Intakes: framework for the United States and Canada. Am J Clin Nutr 94: 655S-7S, 2011.
17. Binkley N, Dawson-Hughes B, Durazo-Arvizu R, Thamm M, Tian L, Merkel JM, Jones JC, Carter GD and Sempos CT: Vitamin D measurement standardization: The way out of the chaos. J Steroid Biochem Mol Biol 173: 117-121, 2017.
18. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS and Hewison M: Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 144: 132-137, 2014.
19. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2016. Scientific opinion on dietary reference values for vitamin D: EFSA Journal 14: 4547, 145 pp., 2016.
20. American Academy of Pediatrics, Committee on Nutrition. The prophylactic requirement and the toxicity of vitamin D: Pediatrics 31: 512-525, 1963.
21. Institute of Medicine. Dietary Reference Intakes for calcium and vitamin D: Washington, DC: National Academies Press, 2010.
22. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ and Shapses SA: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53-58, 2011.
23. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the Tolerable Upper Intake Level of vitamin D: EFSA J 10: 2813, 2012.
24. German Nutrition Society. New reference values for vitamin D: Ann Nutr Metab 60: 241-246, 2012.
25. Cashman KD, Hill TR, Lucey AJ, Taylor N, Seamans KM, Muldowney S, Fitzgerald AP, Flynn A, Barnes MS, Horigan G, Bonham MP, Duffy EM, Strain JJ, Wallace JM and Kiely M: Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 88: 1535-1542, 2008.
26. Scientific Advisory Committee on Nutrition Report on Vitamin D and Health. Available online: https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/537616/SACN-Vitamin-D-and-Health-report.pdf (accessed on 12 July 2017)
27. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH and Weaver CM; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911-1930, 2011.
28. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF): European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24: 23-57, 2013.
29. Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, Feskens EJ, Gallagher CJ, Hypponen E, Llewellyn DJ, Stoecklin E, Dierkes J, Kies AK, Kok FJ, Lamberg-Allardt C, Moser U, Pilz S, Saris WH, van Schoor NM, Weber P, Witkamp R, Zittermann A and de Groot LC: Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int 24: 1567-1577, 2013.
30. Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, Proksch N, Pastor F, Netter C, Streichert T, Püschel K and Amling M: Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 25: 305-312, 2010.
31. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA and Taylor CL: IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 97: 1146-1152, 2012.
32. Wahl DA, Cooper C, Ebeling PR, Eggersdorfer M, Hilger J, Hoffmann K, Josse R, Kanis JA, Mithal A, Pierroz DD, Stenmark J, Stöcklin E and Dawson-Hughes B: A global representation of vitamin D status in healthy populations. Arch Osteoporos 7: 155-172, 2012.
33. Pilz S, Dobnig H, Tomaschitz A, Kienreich K, Meinitzer A, Friedl C, Wagner D, Piswanger-Sölkner C, März W and Fahrleitner-Pammer A: Low 25-hydroxyvitamin D is associated with increased mortality in female nursing home residents. J Clin Endocrinol Metab 97: 653-657, 2012.
34. Kiely M and Black LJ: Dietary strategies to maintain adequacy of circulating 25-hydroxyvitamin D concentrations. Scand J Clin Lab Invest Suppl 243: 14-23, 2012.
35. Kiely M and Cashman KD, on behalf of the ODIN Consortium. The ODIN project: development of food-based approaches for prevention of vitamin D deficiency throughout life. Nutr Bull 40: 235-246, 2015.
36. Rooney MR, Harnack L, Michos ED, Ogilvie RP, Sempos CT and Lutsey PL: trends in use of high-dose vitamin D supplements exceeding 1000 or 4000 international units daily, 1999-2014. JAMA 317: 2448-2450, 2017.
37. Riley RD, Higgins JP and Deeks JJ: Interpretation of random effects meta-analyses. BMJ 342: d549, 2011.
38. Vale CL, Rydzewska LH, Rovers MM, Emberson JR, Gueyffier F and Stewart LA; Cochrane IPD Meta-analysis Methods Group. Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study. BMJ 350: h1088, 2015.
39. Cashman KD, Ritz C, Kiely M, Odin Collaborators: Improved dietary guidelines for vitamin d: application of individual participant data (IPD)-level meta-regression analyses. Nutrients 9: 469, 2017.
40. Pilz S, Hahn A, Schön C, Wilhelm M and Obeid R: effect of two different multimicronutrient supplements on vitamin D status in women of childbearing age: a randomized trial. Nutrients 9: 30, 2017.
41. Kupferschmidt K: Uncertain verdict as vitamin D goes on trial. Science 337: 1476-1478, 2012.
42. Pilz S, Rutters F and Dekker JM: Disease prevention: vitamin D trials. Science 338: 883, 2012.
43. Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E, Baggerly K and McDonnell SL: Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial. JAMA 317: 1234-1243, 2017.
44. Scragg R, Stewart AW, Waayer D, Lawes CMM, Toop L, Sluyter J, Murphy J, Khaw KT and Camargo CA Jr.: Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the Vitamin D Assessment Study: a randomized clinical trial. JAMA Cardiol 2: 608-616, 2017.
45. Zittermann A, Ernst JB, Prokop S, Fuchs U, Dreier J, Kuhn J, Knabbe C, Birschmann I, Schulz U, Berthold HK, Pilz S, Gouni- Berthold I, Gummert JF, Dittrich M and Börgermann J: Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily. Eur Heart 38: 2279-2286, 2017.
46. Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, Treiber G, Drechsler C, Ó Hartaigh B, Obermayer-Pietsch B, Schwetz V, Aberer F, Mader J, Scharnagl H, Meinitzer A, Lerchbaum E, Dekker JM, Zittermann A, März W and Tomaschitz A: Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension 65: 1195-1201, 2015.
47. Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, Mathiesen EB, Njølstad I, Løchen ML, März W, Kleber ME, Tomaschitz A, Grübler M, Eiriksdottir G, Gudmundsson EF, Harris TB, Cotch MF, Aspelund T, Gudnason V, Rutters F, Beulens JW, van 't Riet E, Nijpels G, Dekker JM, Grove-Laugesen D, Rejnmark L, Busch MA, Mensink GB, Scheidt-Nave C, Thamm M, Swart KM, Brouwer IA, Lips P, van Schoor NM, Sempos CT, Durazo-Arvizu RA, Škrabáková Z, Dowling KG, Cashman KD, Kiely M and Pilz S: Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One 12: e0170791, 2017.
48. Grant WB and Boucher BJ: Randomized controlled trials of vitamin D and cancer incidence: A modeling study. PLoS One 12: e0176448, 2017.
49. Scragg R: Limitations of vitamin D supplementation trials: Why observational studies will continue to help determine the role of vitamin D in health. J Steroid Biochem Mol Biol, 2017. doi: 10.1016/j.jsbmb.2017.06.006 [Epub ahead of print]
50. Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, Dick W, Willett WC and Egli A: Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med 176: 175- 183, 2016.
51. Verduijn M, Siegerink B, Jager KJ, Zoccali C and Dekker FW: Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol Dial Transplant 25: 1394-1398, 2010.
52. Vimaleswaran KS, Cavadino A, Berry DJ; LifeLines Cohort Study investigators, Jorde R, Dieffenbach AK, Lu C, Alves AC, Heerspink HJ, Tikkanen E, Eriksson J, Wong A, Mangino M, Jablonski KA, Nolte IM, Houston DK, Ahluwalia TS, van der Most PJ, Pasko D, Zgaga L, Thiering E, Vitart V, Fraser RM, Huffman JE, de Boer RA, Schöttker B, Saum KU, McCarthy MI, Dupuis J, Herzig KH, Sebert S, Pouta A, Laitinen J, Kleber ME, Navis G, Lorentzon M, Jameson K, Arden N, Cooper JA, Acharya J, Hardy R, Raitakari O, Ripatti S, Billings LK, Lahti J, Osmond C, Penninx BW, Rejnmark L, Lohman KK, Paternoster L, Stolk RP, Hernandez DG, Byberg L, Hagström E, Melhus H, Ingelsson E, Mellström D, Ljunggren O, Tzoulaki I, McLachlan S, Theodoratou E, Tiesler CM, Jula A, Navarro P, Wright AF, Polasek O; International Consortium for Blood Pressure (ICBP); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium; Global Blood Pressure Genetics (Global BPGen) consortium; Caroline Hayward, Wilson JF, Rudan I, Salomaa V, Heinrich J, Campbell H, Price JF, Karlsson M, Lind L, Michaëlsson K, Bandinelli S, Frayling TM, Hartman CA, Sørensen TI, Kritchevsky SB, Langdahl BL, Eriksson JG, Florez JC, Spector TD, Lehtimäki T, Kuh D, Humphries SE, Cooper C, Ohlsson C, März W, de Borst MH, Kumari M, Kivimaki M, Wang TJ, Power C, Brenner H, Grimnes G, van der Harst P, Snieder H, Hingorani AD, Pilz S, Whittaker JC, Järvelin MR and Hyppönen E: Association of vitamin D status with arterial blood pressure and hypertension risk: a Mendelian randomisation study. Lancet Diabetes Endocrinol 2: 719-729, 2014.
53. Zittermann A, Pilz S, Hoffmann H and März W: Vitamin D and airway infections: a European perspective. Eur J Med Res 21: 14, 2016.
54. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Griffiths CJ, Janssens W, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S Jr., Stelmach I, Kumar GT, Urashima M and Camargo CA Jr. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 356: i6583, 2017.
55. Manousaki D, Mokry LE, Ross S, Goltzman D and Richards JB: Mendelian randomization studies do not support a role for vitamin D in coronary artery disease. Circ Cardiovasc Genet 9: 349-356, 2016.
56. Pilz S, Grübler M, Gaksch M, Schwetz V, Trummer C, Hartaigh BÓ, Verheyen N, Tomaschitz A and März W: Vitamin D and Mortality. Anticancer Res 36: 1379-1387, 2016.
57. Rhead B, Bäärnhielm M, Gianfrancesco M, Mok A, Shao X, Quach H, Shen L, Schaefer C, Link J, Gyllenberg A, Hedström AK, Olsson T, Hillert J, Kockum I, Glymour MM, Alfredsson L and Barcellos LF: Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol Genet 2: e97, 2016.
58. Mokry LE, Ross S, Morris JA, Manousaki D, Forgetta V and Richards JB: Genetically decreased vitamin D and risk of Alzheimer disease. Neurology 87: 2567-2574, 2016.